scholarly journals Progressive resistance training to prevent arm lymphedema in the first year after breast cancer surgery: Results of a randomized controlled trial

Cancer ◽  
2019 ◽  
Vol 125 (10) ◽  
pp. 1683-1692 ◽  
Author(s):  
Gunn Ammitzbøll ◽  
Christoffer Johansen ◽  
Charlotte Lanng ◽  
Elisabeth Wreford Andersen ◽  
Niels Kroman ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Randomized Controlled Trial ◽  
Resistance Training ◽  
Controlled Trial ◽  
Cancer Surgery ◽  
Breast Cancer Surgery ◽  
First Year ◽  
Progressive Resistance Training ◽  
Randomized Controlled ◽  
Arm Lymphedema

scholarly journals Thoracic Paravertebral Blockade Reduces Chronic Postsurgical Pain in Breast Cancer Patients: A Randomized Controlled Trial

Pain Medicine ◽  
2020 ◽  
Vol 21 (12) ◽  
pp. 3539-3547
Author(s):  
Zeng-Mao Lin ◽  
Mu-Han Li ◽  
Feng Zhang ◽  
Xue Li ◽  
Chun-Li Shao ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Randomized Controlled Trial ◽  
Neuropathic Pain ◽  
Controlled Trial ◽  
Cancer Surgery ◽  
Breast Cancer Surgery ◽  
Control Group ◽  
Single Shot ◽  
Randomized Controlled ◽  
Chronic Postsurgical Pain

Abstract Objective To evaluate the effect of multilevel single-shot thoracic paravertebral blockade (PVB) on the occurrence of chronic postsurgical pain (CPSP) in patients undergoing breast cancer surgery. Design A randomized controlled trial with two parallel groups. Setting A tertiary hospital. Methods Patients scheduled for breast cancer surgery were randomized to receive either ultrasound-guided multilevel single-shot PVB from T2 to T5 (the PVB group) or nothing (the control group). Surgery was then performed under general anesthesia. Patients were followed up for 12 months after surgery. The primary end point was incidence of CPSP at six months after surgery. Results A total of 218 patients were enrolled and randomized; of these, 208 and 204 completed six- and 12-month follow-up, respectively. The incidence of CPSP at six months was significantly lower in the PVB group (12.5% [13/104]) than in the control group (24.0% [25/104], relative risk = 0.52, 95% CI = 0.28–0.96, P = 0.031). Pain scores within 48 hours both at rest and with movement were lower in the PVB group than the control group (P = 0.006 and P < 0.001, respectively). The percentages of patients with neuropathic pain were also lower in the PVB group than the control group at both six and 12 months after surgery (P = 0.016 and 0.028, respectively). Adverse events did not differ between groups. Conclusions For patients undergoing breast cancer surgery, multilevel single-shot PVB reduces the incidence of CPSP at six months; it also improves early postoperative analgesia and reduces neuropathic pain at six and 12 months after surgery.

scholarly journals Antibiotic prophylaxis in breast cancer surgery. A randomized controlled trial

2020 ◽  
Vol 35 (9) ◽  
Author(s):  
Rubens Murilo de Athayde Prudencio ◽  
Fabíola Soares Moreira Campos ◽  
Ana Beatriz Alkmim Teixeira Loyola ◽  
Ivanildo Archangelo Junior ◽  
Neil Ferreira Novo ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Randomized Controlled Trial ◽  
Antibiotic Prophylaxis ◽  
Controlled Trial ◽  
Cancer Surgery ◽  
Breast Cancer Surgery ◽  
Randomized Controlled

scholarly journals 2122. Can Chlorhexidine Reduce Bacterial Colonization in Surgical Drains and Surgical Site Infections After Breast Cancer Surgery? A Randomized Controlled Trial

2018 ◽  
Vol 5 (suppl_1) ◽  
pp. S623-S624
Author(s):  
Frida Rivera-Buendía ◽  
Rafael Franco-Cendejas ◽  
Cristina G Román-López ◽  
Patricia Cornejo-Juárez ◽  
Enrique Bargalló-Rocha ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Randomized Controlled Trial ◽  
Bacterial Colonization ◽  
Controlled Trial ◽  
Surgical Site Infections ◽  
Cancer Surgery ◽  
Breast Cancer Surgery ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document